SCHEMBL8516124

SCHEMBL8516124

O=S(=O)(c1ccccc1)c1ccc(Nc2ncnc3ccc(CCN4CC[S+]([O-])CC4)cc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 13/20 0.49
ERBB2 P04626 4/20 0.47
BRAF P15056 1/20 0.43
PIK3CA P42336 1/20 0.41
PIK3CG P48736 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
HIF1A Q16665 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8363554 0.95 EGFR (0.47) EGFRERBB2BRAFPIK3CAPIK3CG
SCHEMBL8541789 0.94 EGFR (0.47) EGFRERBB2BRAFPIK3CAPIK3CG
SCHEMBL8367738 0.88 EGFR (0.47) EGFRERBB2HSD17B10AURKAAURKB
SCHEMBL8368308 0.88 EGFR (0.49) EGFRERBB2BRAFHSD17B10AURKA
SCHEMBL8367387 0.88 EGFR (0.50) EGFRERBB2BRAFHSD17B10MEN1
SCHEMBL8538985 0.87 EGFR (0.47) EGFRERBB2BRAFHSD17B10AURKA
SCHEMBL8364442 0.86 EGFR (0.60) EGFRERBB2AURKAAURKBKDR
SCHEMBL8367792 0.86 EGFR (0.57) EGFRERBB2BRAFHSD17B10KDR
SCHEMBL8367320 0.85 EGFR (0.54) EGFRERBB2BRAFHSD17B10AURKA
SCHEMBL8367305 0.85 EGFR (0.60) EGFRERBB2CLK4AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999035132-A1 HETEROCYCLIC COMPOUNDS GLAXO GROUP LIMITED (GB) 1999-07-15 WO disclosed